Table 7 Post-Enhancement Visual and Refractive Outcomes
From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients
Pre Supracor | Patient A | Patient B | Patient C | Patient D |
|---|---|---|---|---|
UDVA | 20/20 | 20/30 | 20/60 | 20/25 |
UIVA | 20/32 | 20/50 | 20/50 | 20/25 |
UNVA | J5 | J10 | J10 | J10 |
Sphere (D) | +0.50 | +1.25 | +1.75 | +0.50 |
Cylinder (D) | −0.25 | −0.50 | −0.75 | −0.75 |
Spherical Equivalent (D) | +0.375 | +1.00 | +1.375 | +0.125 |
Pre Enhancement | 14 months | 6 months | 1 year | 2 months |
UDVA | 20/20 | 20/25 | 20/20 | 20/25 |
UIVA | 20/25 | 20/16 | 20/40 | 20/25 |
UNVA | J3 | J1 (doubling) | J10 | J5 |
Sphere (D) | Plano | Plano | +0.50 | +0.50 |
Cylinder (D) | −0.25 | −0.50 | 0.00 | −0.25 |
Spherical Equivalent (D) | −0.125 | −0.25 | +0.50 | +0.375 |
Latest follow up | 2.5 years | 1 year | 3 weeks | 6 months |
UDVA | 20/20 | 20/30 | 20/50 | 20/30 |
UIVA | 20/25 | 20/25 | 20/30 | 20/25 |
UNVA | J1 | J1 | J2 | J1 |
Sphere (D) | −0.25 | −1.00 | −0.50 | −0.50 |
Cylinder (D) | −0.25 | −0.50 | −0.25 | −1.00 |
Spherical Equivalent (D) | −0.325 | −1.25 | −0.63 | −1.00 |